Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BILL Holdings
BILL
|
+$41.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.9M |
| 3 |
Gotham Enhanced 500 ETF
GSPY
|
+$35.8M |
| 4 |
PayPal
PYPL
|
+$17.4M |
| 5 |
NATI
National Instruments Corp
NATI
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$14M |
| 2 |
Lam Research
LRCX
|
+$12.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$9.54M |
| 4 |
VMW
VMware, Inc
VMW
|
+$9.3M |
| 5 |
Valvoline
VVV
|
+$9.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.4% |
| 2 | Industrials | 12.68% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Healthcare | 8.73% |
| 5 | Financials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Healthcare Realty
HR
$6.65B
| $7.82M | 0.15% |
453,696
+430,164
| +1,828% | +$6.57M |
|
152
Crane Co
CR
$12B
| $7.8M | 0.14% |
65,995
-3,717
| -5% | -$374K |
|
|
SKX
153
DELISTED
Skechers
SKX
| $7.74M | 0.14% |
124,205
+50,557
| +69% | +$2.72M |
|
154
Gilead Sciences
GILD
$181B
| $7.73M | 0.14% |
95,422
-84,227
| -47% | -$6.55M |
|
155
McKesson
MCK
$100B
| $7.72M | 0.14% |
16,667
+4,700
| +39% | +$2.14M |
|
156
Deckers Outdoor
DECK
$12.5B
| $7.69M | 0.14% |
69,006
-2,712
| -4% | -$276K |
|
157
Costco
COST
$420B
| $7.68M | 0.14% |
11,642
-1,565
| -12% | -$928K |
|
158
Textron
TXT
$14.3B
| $7.67M | 0.14% |
95,436
+14,090
| +17% | +$1.09M |
|
159
Otis Worldwide
OTIS
$27.2B
| $7.66M | 0.14% |
85,671
-43,789
| -34% | -$3.64M |
|
160
Tesla
TSLA
$1.43T
| $7.59M | 0.14% |
30,556
+142
| +0.5% | +$33.7K |
|
161
Rockwell Automation
ROK
$48.5B
| $7.56M | 0.14% |
24,363
+7,880
| +48% | +$2.21M |
|
162
BorgWarner
BWA
$13.8B
| $7.56M | 0.14% |
210,892
-68,329
| -24% | -$2.44M |
|
163
Healthpeak Properties
DOC
$14.8B
| $7.52M | 0.14% |
379,784
+285,325
| +302% | +$5.02M |
|
164
Corpay
CPAY
$27.4B
| $7.47M | 0.14% |
26,441
+12,212
| +86% | +$3.03M |
|
165
Aflac
AFL
$58.2B
| $7.46M | 0.14% |
90,468
+3,696
| +4% | +$298K |
|
166
Assurant
AIZ
$14B
| $7.42M | 0.14% |
44,064
-3,064
| -7% | -$487K |
|
167
Dominion Energy
D
$58.6B
| $7.36M | 0.14% |
156,618
+136,927
| +695% | +$6.11M |
|
168
RTX Corp
RTX
$283B
| $7.33M | 0.14% |
87,070
+59,406
| +215% | +$4.7M |
|
169
TripAdvisor
TRIP
$1.17B
| $7.28M | 0.14% |
338,342
+76,510
| +29% | +$1.34M |
|
170
Hubbell
HUBB
$24.8B
| $7.27M | 0.13% |
22,095
+510
| +2% | +$153K |
|
171
Conagra Brands
CAG
$7.89B
| $7.23M | 0.13% |
252,243
+91,989
| +57% | +$2.58M |
|
172
Organon & Co
OGN
$3.61B
| $7.22M | 0.13% |
501,022
+331,248
| +195% | +$4.51M |
|
173
Carrier Global
CARR
$49.8B
| $7.19M | 0.13% |
125,195
+32,417
| +35% | +$1.72M |
|
174
PPG Industries
PPG
$25.3B
| $7.19M | 0.13% |
48,079
+18,208
| +61% | +$2.46M |
|
175
Iridium Communications
IRDM
$5.19B
| $7.15M | 0.13% |
173,617
+134,603
| +345% | +$5.33M |
|
Similar funds
Joel Greenblatt's Q4 2023 Portfolio in Review
As of Q4 2023, Joel Greenblatt held 1,470 positions worth $5.39B, up 11% from $4.84B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Joel Greenblatt's Q4 2023 filing shows 157 new, 492 increased, 650 reduced and 145 closed positions. Its largest new stake was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M. The largest sale was Pfizer, an estimated $14M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Joel Greenblatt's largest Q4 2023 buy was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M.
- Joel Greenblatt added most to BILL Holdings in Q4 2023, an estimated $41.5M increase.
- Joel Greenblatt's biggest Q4 2023 reduction was Pfizer, cutting an estimated $14M.
- Joel Greenblatt fully exited VMware, Inc in Q4 2023, selling an estimated $9.3M.
- Joel Greenblatt's ten largest holdings make up 24% of its $5.39B portfolio in Q4 2023.
- Joel Greenblatt opened 157 new positions and closed 145 in Q4 2023.
- Joel Greenblatt's portfolio value rose 11% quarter-over-quarter to $5.39B.
Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.